SDC1 and endothelial dysfunction: In HFpEF patients, increased circulating levels of syndecan-1, a glycocalyx shedding biomarker, were associated with endothelial dysfunction and a doubling of plasma syndecan-1 levels increased risk of all-cause mortality and rehospitalisation [120].